Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

SA Interview: The Bear Case For Battleground Stock Altria With Blue Sky Capital

SA Interview: The Bull Case For Battleground Stock Altria With Atlas Research

Philip Morris

Universal Corp

Despite public opinion turning against tobacco, these three tobacco stocks have high dividends and potential to profit from marijuana.

3 Top Tobacco Stocks Still Burning Strong

Citi upgraded Altria Group Inc. (NYSE: MO) as part of a more bullish general outlook on tobacco companies, but dropped its rating on Philip Morris International Inc.

Citi Is More Bullish On Tobacco, Particularly Altria

Procter & Gamble

Which consumer staples stalwart is a better long-term investment?

Better Buy: Procter & Gamble vs. Altria

AT&T

Exxon Mobil

Looking for big yields and underappreciated growth potential? These companies should be on your short list.

3 Top Stocks With High Dividend Yields: MO, T & XOM

CVS Health

Novo Nordisk

Healthcare, Pharmaceuticals and Consumer Staples will be among the sectors outperforming the Dow Jones Industrial Average or S&P 500 during the next recession.

(Economic) Winter Is Coming: 3 Stocks To Prepare

British American Tobacco

But they can't rest easy, because the threat could resurface very soon.

Tobacco Companies Win Temporary Reprieve on Low-Nicotine Cigarettes

Once believed to be a smoking-hot investment, Altria's stake in Cronos has shrunk considerably.

Here's How Much Altria Has Lost on Its Cronos Investment

Alibaba

Salesforce

The world's most successful fund managers bought into this mix of growth and value during the third quarter.

3 Stocks Billionaire Money Managers Can't Stop Buying

AbbVie

Extra Space Storage

Texas Instruments

Shares of AbbVie, Texas Instruments, Extra Space Storage, Altria, and 3M could be worth a spot in a yield-oriented portfolio.

Best Dividend Stocks for December 2019

Ford Motor Company

Dividend stocks are boring but predictable, but that doesn't mean young investors shouldn't look toward them to buy and hold forever.

5 Great Dividend Stocks for Young Investors

Even if it's not official policy, an effective ban may still be implemented.

President Trump Backs Away From an E-Cig Flavor Ban, but It May Not Matter

Altria remains strong despite tobacco industry transformation.

Looking Through The Smoke To Altria’s Future

Avalara Inc

Hormel Foods

JD.com

Unilever

With the holiday season under way, it's time to close out some 2019 positions and start moving money into the top stocks to buy for 2020.

7 Top Stocks to Buy for 2020

Altria stock has resumed moving higher as the vaping crisis fades from the headlines and as MO's value proposition becomes more apparent.
The post It’s Time to Ride the Altria Stock Revival As Vaping Crisis Subsides appeared first on InvestorPlace.

It’s Time to Ride the Altria Stock Revival As Vaping Crisis Subsides

The government almost made all cigarettes "light" cigarettes -- but now won't.

Why Altria Stock Jumped 6% This Morning

Tobacco stocks rose Wednesday after Bloomberg reported that the Food and Drug Administration has shelved its plan to cut nicotine levels in cigarettes to minimally or non-addictive levels.

Tobacco stocks rise on report that FDA won't cut nicotine levels in cigarettes as planned

Altria (NYSE: MO) made a substantial loss of $2.6 billion in Q3 2019 against a net profit of $2 billion in Q2 2019 and $1.9 billion in Q3 2018. This marks a sequential decline of a whopping 230% in net income during the third quarter compared to Q2 2019.

Why Did Altria Take A Hit Of $4.5 Billion On Its Bottom Line?

American Electric Power Company

Chevron

Dollar General

Disney

General Mills

Johnson & Johnson

Papa John's

Verizon

Verizon Communications Inc 5.9 % Notes 2014-15.2.54 Sr

With the U.S. and China moving toward a trade dispute resolution, the markets have responded with incredibly bullish fervor.

9 Tantalizing Dividend Stocks for 2020

PepsiCo

Which of these industry giants should you buy for the long term?

Better Buy:  PepsiCo vs.  Altria

The tobacco giant has confronted a lot of controversy this year, leading investors to question whether it's still a good buy.

Is Altria a Great Dividend Stock?

Persistent bad news has driven the tobacco company to its lowest valuation in 10 years. It’s time to have a second look.

Is Altria Going Up in Smoke or Just Going Up?

Altria: Time For An Entry Point

This could become the new normal for tobacco companies.

News for Altria Stock (MO)